Overview
Beraprost is a synthetic analogue of prostacyclin, under clinical trials for the treatment of pulmonary hypertension. It is also being studied for use in avoiding reperfusion injury.
Indication
For the treatment of pulmonary hypertension.
Associated Conditions
- Cystic Fibrosis (CF)
- Pain
- Ulcers
- Sensations of cold
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2021/11/02 | Early Phase 1 | UNKNOWN | Shenzhen People's Hospital | ||
2018/09/25 | Phase 4 | UNKNOWN | |||
2018/02/13 | Phase 4 | Completed | Dr. Soetomo General Hospital | ||
2017/05/05 | Not Applicable | UNKNOWN | |||
2016/06/01 | Phase 4 | Terminated | |||
2015/06/24 | Phase 2 | Completed | |||
2013/07/26 | Phase 3 | Completed | |||
2013/02/21 | Not Applicable | UNKNOWN | |||
2011/10/24 | Phase 3 | Withdrawn | |||
2011/09/29 | Phase 1 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Beraprost Sodium Tablets | 国药准字H20253082 | 化学药品 | 片剂 | 1/8/2025 | |
| Beraprost Sodium Tablets | 国药准字H20253372 | 化学药品 | 片剂 | 2/11/2025 | |
| Beraprost Sodium Tablets | 国药准字H20234630 | 化学药品 | 片剂 | 12/13/2023 | |
| Beraprost Sodium Tablets | 国药准字H20243966 | 化学药品 | 片剂 | 6/11/2024 | |
| Beraprost Sodium Tablets | 国药准字H20243696 | 化学药品 | 片剂 | 5/15/2024 | |
| Beraprost Sodium Tablets | 国药准字H20249757 | 化学药品 | 片剂 | 12/17/2024 | |
| Beraprost Sodium Tablets | 国药准字HJ20181057 | 化学药品 | 片剂 | 11/4/2022 | |
| Beraprost Sodium Tablets | 国药准字H20083589 | 化学药品 | 片剂（薄膜衣片） | 11/11/2022 | |
| Beraprost Sodium Tablets | 国药准字H20083588 | 化学药品 | 片剂（薄膜衣片） | 11/11/2022 | |
| Beraprost Sodium Tablets | 国药准字H20244522 | 化学药品 | 片剂 | 7/30/2024 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.